HeyJaredRob Volansky
- Indexed articles, last 90 days
- 25
- Latest publication
- Sep 24, 2026
- Outlet visibility, for Healio
- Top 500K sites
- Earliest in this view
- Jul 9, 2026
Latest articles
âPain is a real diseaseâ: Treating chronic pain requires multidisciplinary approach (opens the original)
Read excerpt
HUNTINGTON BEACH, Calif. — Rheumatologists should be open to antidepressant use or referral to psychiatry for patients experiencing chronic pain, according to a presenter at the Congress of Clinical Rheumatology West. “Pain affects one in five individuals in the U.S. and is disabling for 8% of the population,” Traci J. Speed, MD, PhD, director of the Pain Treatment and Chronic Pancreatitis Pain programs at Johns Hopkins Medicine, told Healio in an interview. “Individuals with rheumatic diseases
Speaker: SetPoint Systemâs effectiveness increasing âover timeâ in rheumatoid arthritis (opens the original)
Read excerpt
HUNTINGTON BEACH, Calif. — Vagus nerve stimulation with the SetPoint System offers a new and promising approach for patients with refractory rheumatoid arthritis, according a speaker at the Congress of Clinical Rheumatology West. “Vagal nerve stimulation is a new option now proven for patients with RA,” Jeffrey Curtis, MD, MS, MPH, Marguerite Jones Harbert-Gene V. Ball endowed professor of medicine at the University of Alabama at Birmingham, told Healio. “It is the first new mechanism of action
FDA fast tracks Yutrepia for Raynaudâs phenomenon in systemic sclerosis (opens the original)
Read excerpt
The FDA has granted fast track designation to Yutrepia for the treatment of Raynaud’s phenomenon associated with systemic sclerosis, according to a press release from the manufacturer. Yutrepia (Liquidia) is an inhalable dry-powder formulation of treprostinil designed to be administered via a “a convenient, low-effort, palm-sized device,” the release said. The drug is currently approved for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial l
Study: Assisted conception may be associated with pediatric Kawasaki disease risk (opens the original)
Read excerpt
Three methods of assisted conception were associated with Kawasaki disease among children aged younger than 5 years, according to data from a Japanese cohort published in JAMA Network Open. “In 2023, approximately 11.7% of all live births in Japan resulted from assisted reproductive technology (ART), which is substantially higher than the rates in Europe (7.9%) and the U.S. (5.1%),” Sachiko Baba, MD, PhD, of the Osaka Women’s and Children’s Hospital, in Izumi, Japan, and colleagues, wrote. “Give
New ACR osteoarthritis guidelines urge shared decision-making, individualized treatment (opens the original)
Read excerpt
The American College of Rheumatology has updated clinical guidance recommendations for the management of osteoarthritis. âThese updated recommendations recognize that there is no single treatment pathway that fits every person living with osteoarthritis,â Sharon L. Kolasinski, MD, principal investigator at the Perelman School of Medicine, University of Pennsylvania, said in an ACR press release. âOur strongest recommendations continue to center on helping people build confidence in managin
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 500K sites
For Healio, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.